Literature DB >> 26453778

Chitosan grafted low molecular weight polylactic acid for protein encapsulation and burst effect reduction.

Antonio Di Martino1, Pavel Kucharczyk1, Jiri Zednik2, Vladimir Sedlarik3.   

Abstract

Chitosan and chitosan-grafted polylactic acid as a matrix for BSA encapsulation in a nanoparticle structure were prepared through a polyelectrolyte complexation method with dextran sulfate. Polylactic acid was synthetized via a polycondensation reaction using the non-metal-based initiator methanesulfonic acid and grafted to the chitosan backbone by a coupling reaction, with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide as the condensing agent. The effect of concentration of the polymer matrix utilized herein on particle diameter, ζ-potential, encapsulation efficiency, and the release kinetic of the model protein bovine serum albumin at differing pH levels was investigated. The influence of pH and ionic strength on the behavior of the nanoparticles prepared was also researched. Results showed that grafting polylactic acid to chitosan chains reduced the initial burst effect in the kinetics of BSA release from the structure of the nanoparticles. Furthermore, a rise in encapsulation efficiency of the bovine serum albumin and diminishment in nanoparticle diameter were observed due to chitosan modification. The results suggest that both polymers actually show appreciable encapsulation efficiency; and release rate of BSA. CS-g-PLA is more suitable than unmodified CS as a carrier for controlled protein delivery.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  2-Hydroxypropanoic acid (PubChem CID: 612); Bovine serum albumin; Bovine serum albumin (PubChem SID: 56312734); Chitosan; Chitosan (PubChem CID: 71853); Controlled drug delivery; Nanoparticles; Polylactic acid

Mesh:

Substances:

Year:  2015        PMID: 26453778     DOI: 10.1016/j.ijpharm.2015.10.017

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Enhancement of temozolomide stability by loading in chitosan-carboxylated polylactide-based nanoparticles.

Authors:  Antonio Di Martino; Pavel Kucharczyk; Zdenka Capakova; Petr Humpolicek; Vladimir Sedlarik
Journal:  J Nanopart Res       Date:  2017-02-16       Impact factor: 2.253

2.  Mechanism of hepatic targeting via oral administration of DSPE-PEG-cholic acid-modified nanoliposomes.

Authors:  Ying Li; Chunyan Zhu
Journal:  Int J Nanomedicine       Date:  2017-02-28

3.  Development of doxorubicin loading platform based albumin-sporopollenin as drug carrier.

Authors:  Esra Maltas; Ilkay Hilal Gubbuk; Salih Yildiz
Journal:  Biochem Biophys Rep       Date:  2016-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.